Sofia Karageorgopoulou
Impact in
-
- Sperm and Testicular Function
- Ovarian cancer diagnosis and treatment
-
- COVID-19 and healthcare impacts
- PARP inhibition in cancer therapy
Papers in
- Oncology 9
- Cancer Diagnosis and Treatment 2
- Cancer Risks and Factors 2
- Cancer survivorship and care 2
-
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Amanda Psyrri (4 shared papers)Eleni Boutati (1 shared paper)Anna Koumarianou (8 shared papers)Helena Linardou (2 shared papers)George Vaiopoulos (1 shared paper)Maria Gazouli (1 shared paper)Maria Skondra (3 shared papers)Nikolaos Spanakis (1 shared paper)
- Journals
- Cancers (5 papers)Journal of Clinical Oncology (3 papers)Journal of Music Therapy (1 paper)European Journal of Cancer (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- GreeceCyprusUnited States
In The Last Decade
Sofia Karageorgopoulou
17 papers receiving 125 citations
Peers
Comparison fields: 5 of 39
- Reproductive Medicine 18
- Oncology 46
- Otorhinolaryngology 6
- Infectious Diseases 24
- Health 8
Countries citing papers authored by Sofia Karageorgopoulou
This map shows the geographic impact of Sofia Karageorgopoulou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Karageorgopoulou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Karageorgopoulou more than expected).
Fields of papers citing papers by Sofia Karageorgopoulou
This network shows the impact of papers produced by Sofia Karageorgopoulou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Karageorgopoulou. The network helps show where Sofia Karageorgopoulou may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofia Karageorgopoulou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 29 | |
| 2 | 2011 | 23 | |
| 3 | 2009 | 20 | |
| 4 | 2017 | 13 | |
| 5 | 2023 | 11 | |
| 6 | Solitary spleen metastasis and amyloidosis in a patient with endometrial cancer. | 2004 | 9 |
| 7 | Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience. | 2009 | 5 |
| 8 | 2024 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2025 | 2 | |
| 12 | 2013 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2014 | 1 | |
| 18 | 2024 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2022 | 0 |
About Sofia Karageorgopoulou
Sofia Karageorgopoulou is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Genetics, having authored 20 papers that have together received 128 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), BRCA gene mutations in cancer (3 papers), DNA Repair Mechanisms (2 papers), Cancer Diagnosis and Treatment (2 papers), Cancer Risks and Factors (2 papers), Cancer survivorship and care (2 papers), CRISPR and Genetic Engineering (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Reproductive Medicine (18 citations), Oncology (46 citations), Otorhinolaryngology (6 citations), Infectious Diseases (24 citations) and Health (8 citations). Sofia Karageorgopoulou has collaborated with scholars based in Greece, Cyprus and United States. Frequent co-authors include Amanda Psyrri, Eleni Boutati, Anna Koumarianou, Helena Linardou, George Vaiopoulos, Maria Gazouli, Maria Skondra, Nikolaos Spanakis, T. Economopoulos and Ioannis D. Kostakis. Their work appears in journals such as Cancers, Journal of Clinical Oncology, Journal of Music Therapy, European Journal of Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.